195 related articles for article (PubMed ID: 10897223)
1. [Current problems of early phase clinical trials for new anticancer agents in Japan].
Nakagawa K; Fukuoka M
Gan To Kagaku Ryoho; 2000 Jun; 27(6):925-9. PubMed ID: 10897223
[TBL] [Abstract][Full Text] [Related]
2. [Current status and problems in clinical trial for new anticancer drug in Japan].
Fukuoka M
Gan To Kagaku Ryoho; 1996 Jan; 23(2):141-5. PubMed ID: 8611040
[TBL] [Abstract][Full Text] [Related]
3. [Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer].
Ueno T; Kobayashi T; Inoue K; Yanagi Y; Yamada Y
Gan To Kagaku Ryoho; 1998 Apr; 25(5):663-70. PubMed ID: 9571963
[TBL] [Abstract][Full Text] [Related]
4. [International clinical trials for a medical oncologist in Japan].
Nakagawa K
Gan To Kagaku Ryoho; 2007 Feb; 34(2):320-3. PubMed ID: 17301554
[TBL] [Abstract][Full Text] [Related]
5. [Development of an anticancer drug in Japan based on a new clinical trial system].
Nakashima H; Nakano S
Gan To Kagaku Ryoho; 1998 Feb; 25(3):287-94. PubMed ID: 9492818
[TBL] [Abstract][Full Text] [Related]
6. [Our policy and future tasks related to ICH in anti-cancer drug development--a discussion from the viewpoint of an enterprise].
Ekimoto H
Gan To Kagaku Ryoho; 1997 Jan; 24(2):229-37. PubMed ID: 9030236
[TBL] [Abstract][Full Text] [Related]
7. Performing phase I clinical trials of anticancer agents: perspectives from within the European union and Japan.
Forster MD; Saijo N; Seymour L; Calvert H
Clin Cancer Res; 2010 Mar; 16(6):1737-44. PubMed ID: 20215555
[TBL] [Abstract][Full Text] [Related]
8. [Globalization of clinical trials].
Akaza H; Fukuoka M; Ohtsu A; Usami M; Ikeda T; Aiba K; Isonishi S; Ohashi Y; Saijo N; Sone S; Tsukagoshi S; Tsuruo T; Kato M; Mikami O; Dong RP; von Euler M; Blackledge G; Stribling D
Gan To Kagaku Ryoho; 2003 Apr; 30(4):555-65. PubMed ID: 12722692
[TBL] [Abstract][Full Text] [Related]
9. The pharmaceutical industry and oncology in central and eastern Europe.
Ben-Am M; Gemperli B; Covelli A; Burke G
Ann Oncol; 1999; 10 Suppl 6():15-7. PubMed ID: 10676548
[TBL] [Abstract][Full Text] [Related]
10. [Contribution of Japan to develop new anticancer agents].
Sajjo N
Gan To Kagaku Ryoho; 1996 Jan; 23(2):242-6. PubMed ID: 8611054
[TBL] [Abstract][Full Text] [Related]
11. Current status and problems in development of molecular target agents for gastrointestinal malignancy in Japan.
Boku N
Jpn J Clin Oncol; 2010 Mar; 40(3):183-7. PubMed ID: 20047861
[TBL] [Abstract][Full Text] [Related]
12. Development of cancer cooperative groups in Japan.
Fukuda H
Jpn J Clin Oncol; 2010 Sep; 40(9):881-90. PubMed ID: 20670961
[TBL] [Abstract][Full Text] [Related]
13. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
Pflieger M; Bertram D
Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
[TBL] [Abstract][Full Text] [Related]
14. [Implementation of new Japanese GCP and the quality of clinical trials--from the standpoint of the pharmaceutical industry].
Ebi O
Gan To Kagaku Ryoho; 1997 Oct; 24(13):1883-91. PubMed ID: 9350232
[TBL] [Abstract][Full Text] [Related]
15. [Future directions of anticancer drug development in Japan].
Akaza H; Kawai K; Tsuruo T; Tsukagoshi S; Aiba K; Shimada Y; Kakeji Y; Ishikawa H; Ikeda T; Nakamura S; Tamura T; Yamamoto N; Isonishi S; Hinotsu S; Hirose M; Katsura J
Gan To Kagaku Ryoho; 2008 Feb; 35(2):351-60. PubMed ID: 18281781
[TBL] [Abstract][Full Text] [Related]
16. [Topoisomerase inhibitors developing in Japan].
Furue H
Gan To Kagaku Ryoho; 1993 Jan; 20(1):42-9. PubMed ID: 8422186
[TBL] [Abstract][Full Text] [Related]
17. The history and future of the Urologic Oncology Study Group (UOSG) of the Japan Clinical Oncology Group (JCOG).
Tobisu K
Jpn J Clin Oncol; 2012 May; 42(5):363-7. PubMed ID: 22450928
[TBL] [Abstract][Full Text] [Related]
18. [New cancer therapies: balancing risk and benefit].
Rothenberg ML
Gan To Kagaku Ryoho; 1998 May; 25(6):797-9. PubMed ID: 9617315
[TBL] [Abstract][Full Text] [Related]
19. Novel camptothecin derivatives.
Legarza K; Yang LX
In Vivo; 2005; 19(1):283-92. PubMed ID: 15796188
[TBL] [Abstract][Full Text] [Related]
20. [Improving the infrastructure for clinical trials in Japan].
Nakano S
Gan To Kagaku Ryoho; 1999 Jan; 26(2 Suppl):225-30. PubMed ID: 9987523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
